Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Alexandersen

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Bone|July 12, 2005
Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: a new potential treatment of osteoarthritisYu Z Bagger, László B Tankó, Peter Alexandersen, et al.
Bone|November 4, 2006
Disassociation of bone resorption and formation by GLP-2: a 14-day study in healthy postmenopausal womenDennis B Henriksen, Peter Alexandersen, Bolette Hartmann, et al.
Menopause (New York, N.Y.)|April 26, 2013
Role of hormones in cartilage and joint metabolism: understanding an unhealthy metabolic phenotype in osteoarthritisAnne C Bay-Jensen, Eline Slagboom, Pingping Chen-An, et al.
Bone|July 28, 2009
Four-month treatment with GLP-2 significantly increases hip BMD: a randomized, placebo-controlled, dose-ranging study in postmenopausal women with low BMDDennis B Henriksen, Peter Alexandersen, Bolette Hartmann, et al.
Osteoarthritis and Cartilage|May 2, 2024
The efficacy and safety of a fixed-dose combination of apocynin and paeonol, APPA, in symptomatic knee OA: A double-blind, randomized, placebo-controlled, clinical trialAsger R Bihlet, Inger Byrjalsen, Jeppe R Andersen, et al.
Bone|March 31, 2004
Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF studyYu Z Bagger, László B Tankó, Peter Alexandersen, et al.
Osteoarthritis and Cartilage|November 9, 2025
The impact of screening period pain inconsistency on placebo response in intra-articular knee osteoarthritis trialsJakob Mejdahl Bentin, Ida Sofie Adrian, Alejandro Castillo Mondragon, et al.
Osteoarthritis and Cartilage|July 3, 2024
A phase 2b double-blind placebo-controlled randomized clinical trial of SB-061, an aggrecan mimetic, in patients with symptomatic knee osteoarthritisAsger R Bihlet, Inger Byrjalsen, Kamilla Mundbjerg, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 16, 2003
Role of gastrointestinal hormones in postprandial reduction of bone resorptionDennis B Henriksen, Peter Alexandersen, Nina H Bjarnason, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 18, 2004
Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnoverLászló B Tankó, Yu Z Bagger, Peter Alexandersen, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Bone|July 12, 2005
Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: a new potential treatment of osteoarthritisYu Z Bagger, László B Tankó, Peter Alexandersen, et al.
Bone|November 4, 2006
Disassociation of bone resorption and formation by GLP-2: a 14-day study in healthy postmenopausal womenDennis B Henriksen, Peter Alexandersen, Bolette Hartmann, et al.
Menopause (New York, N.Y.)|April 26, 2013
Role of hormones in cartilage and joint metabolism: understanding an unhealthy metabolic phenotype in osteoarthritisAnne C Bay-Jensen, Eline Slagboom, Pingping Chen-An, et al.
Bone|July 28, 2009
Four-month treatment with GLP-2 significantly increases hip BMD: a randomized, placebo-controlled, dose-ranging study in postmenopausal women with low BMDDennis B Henriksen, Peter Alexandersen, Bolette Hartmann, et al.
Osteoarthritis and Cartilage|May 2, 2024
The efficacy and safety of a fixed-dose combination of apocynin and paeonol, APPA, in symptomatic knee OA: A double-blind, randomized, placebo-controlled, clinical trialAsger R Bihlet, Inger Byrjalsen, Jeppe R Andersen, et al.
Bone|March 31, 2004
Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF studyYu Z Bagger, László B Tankó, Peter Alexandersen, et al.
Osteoarthritis and Cartilage|November 9, 2025
The impact of screening period pain inconsistency on placebo response in intra-articular knee osteoarthritis trialsJakob Mejdahl Bentin, Ida Sofie Adrian, Alejandro Castillo Mondragon, et al.
Osteoarthritis and Cartilage|July 3, 2024
A phase 2b double-blind placebo-controlled randomized clinical trial of SB-061, an aggrecan mimetic, in patients with symptomatic knee osteoarthritisAsger R Bihlet, Inger Byrjalsen, Kamilla Mundbjerg, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 16, 2003
Role of gastrointestinal hormones in postprandial reduction of bone resorptionDennis B Henriksen, Peter Alexandersen, Nina H Bjarnason, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 18, 2004
Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnoverLászló B Tankó, Yu Z Bagger, Peter Alexandersen, et al.
Pageof 4